Biosergen AB (publ) (STO:BIOSGN)
Sweden · Delayed Price · Currency is SEK 8.10
-0.30 (-3.57%)
Jun 11, 2026, 2:20 PM CET
Biosergen AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
19.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Magle Chemoswed Holding AB | 273.25M |
| Alzinova AB | 25.66M |
| Fluicell AB | 20.15M |
| ExpreS2ion Biotech Holding AB | 16.12M |
| Spago Nanomedical AB | 4.38M |
| Aptahem AB | 2.52M |
| 2cureX AB | 1.98M |
| Pila Pharma AB | 1.13M |
Biosergen AB News
- 4 months ago - Biosergen AB Quarterly report: Q4 2025 - Filings
- 7 months ago - Biosergen AB Quarterly report: Q3 2025 - Filings
- 10 months ago - Biosergen AB Quarterly report: Q2 2025 - Filings